These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 27432879)

  • 1. Amphiregulin Confers Regulatory T Cell Suppressive Function and Tumor Invasion via the EGFR/GSK-3β/Foxp3 Axis.
    Wang S; Zhang Y; Wang Y; Ye P; Li J; Li H; Ding Q; Xia J
    J Biol Chem; 2016 Sep; 291(40):21085-21095. PubMed ID: 27432879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphiregulin enhances regulatory T cell-suppressive function via the epidermal growth factor receptor.
    Zaiss DM; van Loosdregt J; Gorlani A; Bekker CP; Gröne A; Sibilia M; van Bergen en Henegouwen PM; Roovers RC; Coffer PJ; Sijts AJ
    Immunity; 2013 Feb; 38(2):275-84. PubMed ID: 23333074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain Foxp3
    Guo S; Luo Y
    Int Immunopharmacol; 2020 Apr; 81():106027. PubMed ID: 31791672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ring finger protein 31-mediated atypical ubiquitination stabilizes forkhead box P3 and thereby stimulates regulatory T-cell function.
    Zhu F; Yi G; Liu X; Zhu F; Zhao A; Wang A; Zhu R; Chen Z; Zhao B; Fang S; Yu X; Lin R; Liang R; Li D; Zhao W; Zhang Z; Guo W; Zhang S; Ge S; Fan X; Zhao G; Li B
    J Biol Chem; 2018 Dec; 293(52):20099-20111. PubMed ID: 30389786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressive regulatory T cell activity is potentiated by glycogen synthase kinase 3{beta} inhibition.
    Graham JA; Fray M; de Haseth S; Lee KM; Lian MM; Chase CM; Madsen JC; Markmann J; Benichou G; Colvin RB; Cosimi AB; Deng S; Kim J; Alessandrini A
    J Biol Chem; 2010 Oct; 285(43):32852-32859. PubMed ID: 20729209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncoupling between epidermal growth factor receptor and downstream signals defines resistance to the antiproliferative effect of Gefitinib in bladder cancer cells.
    Kassouf W; Dinney CP; Brown G; McConkey DJ; Diehl AJ; Bar-Eli M; Adam L
    Cancer Res; 2005 Nov; 65(22):10524-35. PubMed ID: 16288045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse Double Minute 2 Homolog-Mediated Ubiquitination Facilitates Forkhead Box P3 Stability and Positively Modulates Human Regulatory T Cell Function.
    Wang A; Yang M; Liang R; Zhu F; Zhu F; Liu X; Han Y; Lin R; Wang X; Li D; Li H; Yuan X; Zhao H; Li B
    Front Immunol; 2020; 11():1087. PubMed ID: 32636834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphiregulin potentiates airway inflammation and mucus hypersecretion induced by urban particulate matter via the EGFR-PI3Kα-AKT/ERK pathway.
    Wang J; Zhu M; Wang L; Chen C; Song Y
    Cell Signal; 2019 Jan; 53():122-131. PubMed ID: 30291869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity.
    Pallandre JR; Brillard E; Créhange G; Radlovic A; Remy-Martin JP; Saas P; Rohrlich PS; Pivot X; Ling X; Tiberghien P; Borg C
    J Immunol; 2007 Dec; 179(11):7593-604. PubMed ID: 18025205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Altered Treg and IL-1A Expression in the Immune Microenvironment 
of Lung Squamous-cell Cancer after EGFR Blockade].
    He H; Qi L; Hou Y
    Zhongguo Fei Ai Za Zhi; 2017 Mar; 20(3):143-148. PubMed ID: 28302215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Amphiregulin/EGFR axis protects from lupus nephritis via downregulation of pathogenic CD4
    Melderis S; Warkotsch MT; Dang J; Hagenstein J; Ehnold LI; Herrnstadt GR; Niehus CB; Feindt FC; Kylies D; Puelles VG; Berasain C; Avila MA; Neumann K; Tiegs G; Huber TB; Tharaux PL; Steinmetz OM
    J Autoimmun; 2022 May; 129():102829. PubMed ID: 35468361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Snail regulated by PKC/GSK-3β pathway is crucial for EGF-induced epithelial-mesenchymal transition (EMT) of cancer cells.
    Liu ZC; Chen XH; Song HX; Wang HS; Zhang G; Wang H; Chen DY; Fang R; Liu H; Cai SH; Du J
    Cell Tissue Res; 2014 Nov; 358(2):491-502. PubMed ID: 25124796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor receptor 4 increases epidermal growth factor receptor (EGFR) signaling by inducing amphiregulin expression and attenuates response to EGFR inhibitors in colon cancer.
    Hong CS; Sun EG; Choi JN; Kim DH; Kim JH; Ryu KH; Shim HJ; Hwang JE; Bae WK; Kim HR; Kim KK; Jung C; Chung IJ; Cho SH
    Cancer Sci; 2020 Sep; 111(9):3268-3278. PubMed ID: 32533590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling Through gp130 Compromises Suppressive Function in Human FOXP3
    Bin Dhuban K; Bartolucci S; d'Hennezel E; Piccirillo CA
    Front Immunol; 2019; 10():1532. PubMed ID: 31379810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycogen synthase kinase 3β in tumorigenesis and oncotherapy (Review).
    He R; Du S; Lei T; Xie X; Wang Y
    Oncol Rep; 2020 Dec; 44(6):2373-2385. PubMed ID: 33125126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sprouty2 inhibits amphiregulin-induced down-regulation of E-cadherin and cell invasion in human ovarian cancer cells.
    Cheng JC; Chang HM; Xiong S; So WK; Leung PC
    Oncotarget; 2016 Dec; 7(49):81645-81660. PubMed ID: 27835572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium controlled NFATc1 activation enhances suppressive capacity of regulatory T cells isolated from generalized vitiligo patients.
    Giri PS; Bharti AH; Begum R; Dwivedi M
    Immunology; 2022 Nov; 167(3):314-327. PubMed ID: 35754117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen Synthase Kinase-3β (GSK-3β) Inhibition Enhances Dendritic Cell-based Cancer Vaccine Potency via Suppression of Interferon-γ-induced Indoleamine 2,3-Dioxygenase Expression.
    Noh KT; Son KH; Jung ID; Kang TH; Choi CH; Park YM
    J Biol Chem; 2015 May; 290(19):12394-402. PubMed ID: 25814664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-1 receptor inhibition overcomes gefitinib resistance in mucinous lung adenocarcinoma.
    Hurbin A; Wislez M; Busser B; Antoine M; Tenaud C; Rabbe N; Dufort S; de Fraipont F; Moro-Sibilot D; Cadranel J; Coll JL; Brambilla E
    J Pathol; 2011 Sep; 225(1):83-95. PubMed ID: 21598249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrin-releasing peptide activates Akt through the epidermal growth factor receptor pathway and abrogates the effect of gefitinib.
    Liu X; Carlisle DL; Swick MC; Gaither-Davis A; Grandis JR; Siegfried JM
    Exp Cell Res; 2007 Apr; 313(7):1361-72. PubMed ID: 17349623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.